Piramal Pharma Solutions leveraged its CDMO expertise to help George Medicines develop WIDAPLIK, the first and only FDA-approved triple combination therapy for hypertension, combining telmisartan, amlodipine, and indapamide to effectively lower blood pressure.
Peter DeYoung | 01/09/2025 | By Mrinmoy Dey
Piramal Pharma, NewAmsterdam Launch Dedicated OSD Suite at Sellersville Site in US
Piramal Pharma Solutions and NewAmsterdam Pharma have inaugurated a dedicated oral solid dosage (OSD) suite at Piramal’s Sellersville, Pennsylvania facility to support the production of NewAmsterdam’s investigational fixed-dose combination cholesterol therapy.
Peter DeYoung | 21/08/2025 | By Mrinmoy Dey | 104
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy